RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bindong Liu to China

This is a "connection" page, showing publications Bindong Liu has written about China.
Connection Strength

0.806
  1. Yang Y, Lin LH, Gao M, Tang RN, Ma KL, Tu Y, Liu H, Liu BC. Association Between the Serum Uric Acid Level and the Severity of Coronary Artery Disease in a Retrospective Study of China Nondialysis CKD Patients. Metab Syndr Relat Disord. 2020 05; 18(4):206-211.
    View in: PubMed
    Score: 0.170
  2. Wei Q, Liu H, Tu Y, Tang RN, Wang YL, Pan MM, Liu BC. The characteristics and mortality risk factors for acute kidney injury in different age groups in China-a cross sectional study. Ren Fail. 2016 Oct; 38(9):1413-1417.
    View in: PubMed
    Score: 0.135
  3. Sun L, Zou LX, Han YC, Huang HM, Tan ZM, Gao M, Ma KL, Liu H, Liu BC. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025. BMC Nephrol. 2016 06 13; 17(1):60.
    View in: PubMed
    Score: 0.132
  4. Han YC, Huang HM, Sun L, Tan CM, Gao M, Liu H, Tang RN, Wang YL, Wang B, Ma KL, Liu BC. Epidemiological Study of RRT-Treated ESRD in Nanjing - A Ten-Year Experience in Nearly Three Million Insurance Covered Population. PLoS One. 2016; 11(2):e0149038.
    View in: PubMed
    Score: 0.129
  5. Liu H, Zhang XM, Wang YL, Liu BC. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol. 2014 Dec; 27(6):653-8.
    View in: PubMed
    Score: 0.113
  6. Zhao MH, Chen W, Cheng H, Liu BC, Mao ZG, Tian Z, Xu G, Zhou JM. A Chinese Multi-Specialty Delphi Consensus to Optimize RAASi Usage and Hyperkalaemia Management in Patients with Chronic Kidney Disease and Heart Failure. Chin Med Sci J. 2024 Jun 30; 39(2):79-90.
    View in: PubMed
    Score: 0.058
  7. Sun F, Bedenkov A, Liu BC, Yang J, Xu JF, Ji L, Zhou M, Zhang S, Li X, Song Y, Chen P, Moreno C. Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings. Pharmaceut Med. 2024 May; 38(3):157-166.
    View in: PubMed
    Score: 0.057
  8. Yu XF, Liu W, Chen J, Kong W, Liu B, Zhu Q, Liang F, McCutchan F, Piyasirisilp S, Lai S. Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01_AE HIV type 1 in southern China. AIDS Res Hum Retroviruses. 2002 Jan 20; 18(2):167-70.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support